Continuous Glucose Monitoring, Contingency Management, and Motivational Interviewing for Patients With Type 2 Diabetes in Kansas City - Trial NCT06374186
Access comprehensive clinical trial information for NCT06374186 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Missouri, Kansas City and is currently Not yet recruiting. The study focuses on Type 2 Diabetes. Target enrollment is 40 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
University of Missouri, Kansas City
Timeline & Enrollment
N/A
May 01, 2024
Apr 08, 2025
Primary Outcome
Time in target blood glucose range per CGM,Hemoglobin A1C
Summary
This study is evaluating a behavioral treatment program that uses diabetes coaching and
 financial rewards in addition to continuous glucose monitoring to improve diabetes management
 in adult patients with type 2 diabetes. This study will evaluate if this behavioral treatment
 program increases individual adherence to a diabetes treatment plan and improves blood sugar
 management.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06374186
Non-Device Trial